Objective: The parasympathetic (P) nervous system is thought to contribute significantly to focal atrial fibrillation (AF). Thus, we hypothesized that P nerve fibers (and related muscarinic receptors) are preferentially located in the posterior left atrium (PLA) and that selective cholinergic blockade in the PLA can be successfully performed to alter vagal AF substrate.
INTRODUCTION
Atrial fibrillation (AF) occurs in a wide spectrum of patients, ranging from no anatomic structural heart disease to all varieties of heart disease with associated atrial pathology. It is therefore no surprise that the pathophysiology of AF is diverse.
Importantly, the role of the autonomic nervous system in the pathogenesis of AF has been demonstrated in multiple settings. Hou et al (10) have suggested the presence of an intricate, interconnecting neural network in the left atrium (LA) that may contribute to substrate for focal AF. A recent human study described heterogeneity of nerve distribution in the region of the pulmonary veins (PVs) and surrounding LA (3).
As both parasympathetic and sympathetic activation may have prominent effects on atrial conduction velocity and refractoriness, regional heterogeneities in nerve distribution could thereby be responsible for the heterogeneities in conduction velocity and refractoriness that are necessary for the initiation and perpetuation of AF. Thus, the distribution of autonomic nerves throughout the atrium could represent a substrate for AF, particularly in settings where there are no anatomic abnormalities.
In a recent study in normal canine hearts, we demonstrated that vagal responsiveness is more pronounced in the posterior left atrium (PLA) and PVs as compared to the rest of the left atrium (2) . In fact, clinical data suggests that focal "triggers" and "drivers" in the PV (even in structurally normal hearts) appear to be at least partially modified or regulated by the parasympathetic nervous system (11) . In light of these prior studies, we hypothesized that the density of parasympathetic nerves and related muscarinic receptors is greater in the PLA than in the rest of the LA, with the parasympathetic innervation of the PLA playing an important role in the creation of AF substrate in structurally normal hearts. We also postulated that selective cholinergic blockade in this region can be attained by pharmacological methods, with a resulting 6
METHODS

The investigation conforms with the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) . Approval for use of purpose-bred dogs (hounds) was obtained from the institutional Animal Use Committee.
Immunostaining:
PVs were harvested from normal, healthy dogs. The pulmonary veins were taken as the region extending from the antrum to the junction of the left atrial myocardium/PV smooth muscle. The adjoining PLA (defined as the confluence of the PVs) and the anterior LA (LAA) were also harvested. Regions containing fat were always incorporated in the tissue sections taken from the PLA. Control specimens were taken from the cervical vagus nerve and stellate ganglia. The tissue was frozen in liquid nitrogen. Serial circumferential cross-sections were cut (proximal-to-distal) from the PVs (Figure 1 ). Sections from the posterior and anterior LA were cut parallel to the plane of the mitral annulus so as to include the epicardial and endocardial aspect of the myocardium in each slice (Figure 1 ).
Sections were air dried and fixed in acetone for 10 min, then washed in Trisbuffered saline (TBS). Hydrogen peroxidase block (Dako, Carpinteria, CA) was placed on the sections for 10 min, and then the slides were again washed in TBS. Protein block was placed on the sections for 30 min. Primary antibodies were then incubated overnight at 4º C. Antibodies for dopamine beta-hydroxylase (DBH; Chemicon, Temecula, CA) were used to stain sympathetic nerves, while antibodies for choline acetyltransferase (ChAT; Chemicon) were used to stain parasympathetic nerves. The specificity of DBH for sympathetic nerve fibers was confirmed by the use of a second 7 sympathetic marker i.e. tyrosine hydroxylase (TH; Chemicon); TH was noted to stain the same nerve elements that were being stained by DBH ( figure 2 A,B) . Similarly, the specificity of parasympathetic staining was confirmed by the use of second parasympathetic marker i.e. acetylcholine esterase (ACE; Chemicon); ACE was found to stain the same nerve elements that were being stained by ChAT (data not shown).
Some sections were double-stained for both ChAT and DBH. After incubation, the slides were washed in TBS and the appropriate secondary antibody (Chemicon) was then placed on the sections for 30 minutes. The sections were again washed in TBS and the appropriate chromagen was added to each specimen. Sympathetic nerves were stained blue (BCIP); parasympathetic nerves were stained brown (DAB). Cell nuclei were marked by placing the specimens in methyl green (Dako, Carpinteria, CA) for 10 min. The specimens were then dehydrated in alcohol, mounted, and examined under light microscopy. Similar techniques have previously been used to successfully characterize the autonomic innervation of other tissues (13, 26) .
Cardiac ganglia were defined as nerve bundles containing one or more neuronal cell bodies (26) . The presence of neuronal cell bodies within nerve bundles was confirmed by staining these bundles for hematoxylin; all neuronal cell bodies stained positive for hematoxylin (data not shown), thereby excluded the presence of fat cells within these bundles.
Specimens taken from the cervical vagus nerve served as a positive control for parasympathetic nerve fibers, but negative control for sympathetic nerves. On the other hand, speciments from the stellate ganglia served as a positive control for sympathetic fibers, but a negative control for parasympathetic nerve fibers (control data not shown).
Separate slides were immunostained for muscarinic receptors (M2; Abcam, Cambridge, MA). The staining technique was as described above for ACE and DBH.
M2 receptors were stained brown (DAB).
Electrophysiological studies
Electrophysiologic studies were performed in 7 additional animals in order to discover the physiologic significance of the results obtained from the immunohistochemical studies. Immunostaining was not performed on animals undergoing electrophysiologic testing as sufficient immunohistochemical data had already been obtained from 6 dogs. In addition, 2 additional animals were used to assess for any systemic absorption of tropicamide (see below).
In vivo experiments were performed under general anesthesia (2.5% inhaled isoflurane; preanesthesia with intravenous propofol 4.5mg/kg). The left cervical vagus was isolated in the neck. The chest was opened via a median thoracotomy. Epicardial, bipolar mapping was performed in the left atrium and PVs. All data was acquired by a 128-channel mapping system (Prucka Cardiolab, GE, WI) at a sampling rate of 977 Hz.
Multielectrode plaques were sutured on the PVs (2x2 electrodes), PLA (7x3 electrodes) and LAA (7x3 electrodes). Bipolar pacing was performed from multiple sites on the PLA and LAA plaques and from one site on each PV plaque. ERPs were obtained at each site where bipolar pacing was performed. ERPs were obtained at 11±4 sites for each stage/intervention (see interventions below). Effective refractory periods (ERP)
were measured with a drive train of 8 stimuli (S1=400 ms) at twice diastolic threshold followed by a single premature stimulus (S2) coupled with decrements of 10 ms until local ERP was reached. ERP were obtained at baseline and in response left cervical vagal stimulation (VS) which was performed at 20 Hz (15-20V, 2-8 msec, Grass S44G, Astromed Inc, RI) a positive response consisted of: 1) sinus node slowing by at least 25% or 2) PR prolongation by more than 25% or 2:1 AV block. 1% tropicamide (a cholinergic blocker) was then applied topically to the epicardial aspect of the PLA.
After an equilibration time of 15 minutes, ERPs were re-measured in the presence and absence of VS. The same number of extrastimuli were given at each site for each intervention (i.e. Baseline, VS, Tropicamide, Tropicamide + VS). AF induced during ERP testing was analyzed as described in Data Analysis below.
The possibility of diffusion of tropicamide from the PLA to the rest of the left atrium and PVs was excluded by performing a dye diffusion study in one animal. Food coloring dye was mixed in normal saline and was applied to the PLA in this dog. The color remained confined to the PLA even after several hours of application.
In order to assess for systemic absorption of tropicamide, the sinus rate was assessed in 9 animals at the following time points i.e. 1) before the application of tropicamide, 2) 5 minutes after tropicamide application and 3) 30 minutes after tropicamide application. Vagal-induced sinus slowing was also measured at the abovementioned time points. As a surrogate of systemic absorption of tropicamide, in two animals we also examined the pupillary diameter before and after tropicamide application to the heart (5 and 30 minutes).
Data analysis:
Nerve count estimation: Nerve bundles as well as individual nerve fibrils were manually counted at 10X magnification for the entire section. Nerve bundles or trunks were defined as large collections of individual nerve fibers/fibrils with a diameter 0.025 cm. Nerve fibrils were defined as thin nerve fibers with diameters of <20µm (26) . Nerve bundle density was calculated as the number of nerve bundles per cm 2 . Since individual nerve fibrils were too numerous to be counted for the entire section, parasympathetic as well as sympathetic nerve fibrils were counted in five, evenly spaced grid (10mm x 10mm) fields within each section; the average of these five fields was taken as a measure of the nerve fibril density (per cm 2 ) for the section.
Quantification was separately performed for the epicardial versus the endocardial half of the section.
In addition, the number of cholinergic and adrenergic fibers was counted manually within several, randomly selected nerve bundles that demonstrated colocalization of parasympathetic and sympathetic fibers; at least 5 bundles were selected from each region. To account for variation in nerve/nerve bundle size, the ratio of cholinergic to adrenergic nerve fibers (averaged for the randomly selected bundles from each region) was taken as an estimate of the relative distribution of cholinergic vs adrenergic nerve fibers in each region. 
RESULTS
Tissue from 6 normal, healthy dogs was studied. Sections from PVs (N=22), adjoining PLA (N=6) and LAA (N=6) were stained with ACE and DBH. Separate sections from the PV (N=5), PLA (N=5) and LAA (N=5) were stained for M2 receptor.
Both large nerve bundles (trunks; diameters 0.025 cm) and thin nerve fibrils (diameters <20 µm) were seen in the PV and atrial myocardium ( Figure 2 ). Although nerve bundles were located predominantly in fibrofatty tissue overlying the epicardium (figures 2, 4), 36 % of all nerve bundles were located away from surface fibrofatty tissue in underlying and surrounding myocardium (p=0.001, figure 2D ). On the other hand, thin nerve fibrils were located almost entirely in the myocardium, extending between and parallel to myocardial fibers ( figure 2E ). Nerve bundles, as well as thin nerve fibrils branching out from larger nerve bundles, were situated in close proximity to the vasculature in the all the regions that were studied (figure 2F).
Nerve bundles
Significant differences in nerve bundle density were noted among the PV, PLA and LAA, with the PLA having the greatest density of nerve bundles (PLA>>PV>>LAA, p<0.001; figure 3A ). Nerve bundles were predominantly localized to the epicardial half of the PVs, PLA as well as the LAA ( figure 3B ). The total number of nerve bundles was significantly greater in the superior as compared to the inferior veins (0.96±0.9/cm 2 vs. 0.80±0.8/cm 2 respectively, p=0.04). The density of nerve bundles trended to be higher in the proximal than in the distal segments of the PVs ( 
Sympathetic vs. parasympathetic nerve distribution within nerve bundles
Sympathetic and parasympathetic nerve fibers were found to be co-localized within a large majority of nerve bundles in each region (% of bundles demonstrating colocalization: PV=67%, PLA=87%, LAA=67%, p=NS). The remainder of the nerve bundles was composed purely of parasympathetic fibers. No nerve bundles composed of sympathetic fibers alone were noted in any of the three regions. 
Thin nerve fibrils
As opposed to nerve bundles, both parasympathetic and sympathetic nerve fibrils appeared to be equally distributed between the epi and endocardium of the PLA and the LAA (table 2) . This homogeneity was not observed within the PV, where the sympathetic nerve fibrils were more concentrated on the endocardium (table 2) .
Parasympathetic fibrils were most abundant in the PLA, followed by the LAA and PV (PLA>LAA>PV; p=0.013; figure 5 ). In contrast, sympathetic nerve fibril density was greatest in the LAA, followed by the PV and PLA (LAA>PV PLA, p<0.001; figure 5 ). The density of parasympathetic fibrils was significantly greater than the density of sympathetic fibrils in the PLA (P>S, p=0.034; figure 5 ). No significant difference was noted between the density of parasympathetic and sympathetic fibrils in the LAA and the PV (figure 5; table 2).
The density of sympathetic as well as parasympathetic fibers trended to be greater in the proximal as compared to the distal segments of the PVs (table 1) . There were no significant differences among the PVs with respect to the density of sympathetic or parasympathetic nerve fibrils (table 1) .
Cardiac ganglia
Cardiac ganglia containing parasympathetic neuronal cell bodies (figure 6) were found in the PLA and PV, but not in the LAA (PV PLA>LAA, p=0.04; figure 6C ).
Ganglia consisting of neuronal cell bodies were juxtaposed with bundles of parasympathetic nerve fibers that appeared to arise from the neuronal cell bodies ( figure   6A ).
Even though the majority of cardiac ganglia (86%) containing parasympathetic neuronal cell bodies also contained sympathetic nerve fibers, the proportion of neuronal cell bodies was significantly greater than the proportion of sympathetic fibers (P/S=1.65, P vs. S; p=0.004).
Muscarinic (M2) receptor distribution
Since cholinergic nerve fibers exert their downstream effects principally via M2
receptors, M2 receptor distribution in the LA was assessed. M2 receptors were localized in and around the following structures: 1) nerve bundles and fibers, 2) perivascularly After application of tropicamide, the VS induced ERP shortening was attenuated not just in the PLA but also in the PV and LAA (overall shortening 3.9%, p=NS; figure   8A ).
At baseline, AF was rarely induced using single atrial extrastimuli (inducibility index = 0.018). However, AF was more easily inducible in the presence of VS; twentytwo episodes of greater than 5 seconds duration were induced in the presence of VS with single atrial extrastimuli (inducibility index = 0.12 i.e. 6.6-fold the baseline ratio; baseline vs. VS, p<0.01; figure 8B ). After tropicamide application, AF inducibility was significantly decreased in the presence of VS. Only one episode lasting more than 5 seconds could be induced; the inducibility index was 0.02, which represents a 92 % reduction in AF inducibility (tropicamide + VS vs. VS alone, p<0.001; figure 8B ).
DISCUSSION
The major findings of this study are: 1) parasympathetic nerve trunks and fibers in the LA are preferentially located in the PLA, with nerve trunks being located both in the fat pads as well as in surrounding myocardium, 2) muscarinic (M2) receptor density is also significantly more pronounced in the PLA than in the rest of the LA and 3) since the majority of parasympathetic fibers and M2 receptors in the LA are located in the PLA, selective parasympathetic blockade in the PLA significantly alters vagal responsiveness in the entire LA, with a near-complete elimination of vagal-induced AF.
These results indicate a potentially important role for the parasympathetic innervation of the PLA in the creation of substrate for AF (at least in structurally normal hearts).
Furthermore, our results suggest that a targeted disruption of parasympathetic elements in the PLA may help to successfully modify this substrate.
This study is unique for its therapeutic implications. Since the PLA contains a larger number of parasympathetic fibers and M2 receptors than the rest of the left atrium, our results indicate that a topical strategy targeted to the PLA can be successfully employed to achieve functional parasympathetic blockade in the entire LA.
Role of the parasympathetic innervation of the PLA in genesis of AF
The role of the autonomic nervous system in the genesis of atrial arrhythmias has been extensively studied (12, 17) . Vagal stimulation and/or administration of acetylcholine have also been shown to decrease refractoriness in the LA and enhance inducibility of AF (15) .
Recent clinical studies have shown that several cases of AF can be caused by a rapidly firing focus in the atrium (5-7, 11, 24) . Clinical and animal data suggests that these PV triggers and drivers appear to be at least partially modulated by the autonomic nervous system (11, 24) , with different studies implicating either the sympathetic or the 
Selective parasympathetic denervation of the PLA-a new therapeutic target for AF?
Elimination of vagal reflexes during ablation lesions has been shown in some studies to be correlated with improved PV ablation outcomes (19) . However, other attempts at parasympathetic ablation for AF have been less successful (4, 8) . Current endocardial ablation strategies that target the parasympathetic nervous system of the LA are largely empiric, being guided by non-specific electrophysiologic responses such as sinus bradycardia and AV block (19, 23) . More 'anatomic' approaches that surgically target atrial fat pads have also met with somewhat mixed success (4, 28 ). An added disadvantage of an anatomic approach is that it inevitably causes transmural atrial tissue damage (16) . In addition, the LA is innervated by several fat pads, all of which may not be responsible for the innervation of the PLA and PVs.
An ideal therapeutic strategy would be more precise in targeting the nerves involved in the genesis of AF without causing any significant damage to surrounding tissue (14) . Development of such a targeted approach to focal AF hinges on a better understanding of the complexities of neural innervation of the atria. In a study by Hou et al (10) , electrophysiologic data suggests the presence of an intricate, interconnecting neural network in the LA that may contribute to substrate for focal AF. However, no attempt was made in that study to correlate electrophysiologic responses with the structure, function and distribution of the underlying nerve fibers. A recent human study quantified autonomic nerve distribution in the PVs and surrounding LA and described heterogeneity of nerve distribution in this region (3); the composition of these nerves i.e. sympathetic vs. parasympathetic was not reported in that study.
In this study, we have demonstrated that the PLA is the most richly innervated region of the LA, with parasympathetic fibers comprising a majority of the nerves supplying this area. Importantly, the current study shows that even though a majority of nerve bundles are located within the fat/fibrofatty tissue itself, up to a third of nerve bundles in the PLA can be located away from the fat in adjoining/underlying myocardium.This finding suggests that ablation strategies directed at atrial fat pads would not be expected to result in complete denervation of the PLA. Since vagal nerve fibers and M2 receptors are preferentially localized in the PLA, we postulated that topical, pharmacological disruption of cholinergic function in the PLA would alter vagal responsiveness in the entire LA. Our experiments demonstrate that it is indeed feasible to attain selective cholinergic blockade in this region with a non-ablative, pharmacological approach, with a resulting change in vagal-induced AF substrate.
It is important to realize that focal sources of AF been described elsewhere in the atria e.g. in the SVC, coronary sinus etc. In the present study, we chose to study/target the PLA as a large majority of ectopic foci have been found to be localized to the PVs and PLA. While a targeted approach to the PLA would help attenuate/eliminate focal AF sources in the left atrium it would not be expected to affect other, more distant focal sources in the heart.
Study limitations
This was a canine study, the results of which cannot be directly extrapolated to the human LA. Moreover, this study was conducted in normal dogs and it is not known to what extent autonomic remodeling occurs in the setting of AF. Further studies are therefore needed to assess for neural innervation in more "pathologic"
settings.
The nerve distribution in the left atrium and pulmonary veins is complex as shown by previous anatomic studies (1, 3). In this regard, our study does not provide respectively. In addition, in Armor's study, the posteromedial GP had one of the largest numbers of gangia amongst all the atrial GPs. While we did not perform a gross anatomic dissection in the present study, the site of tropicamide application (at the confluence of PVs) corresponds to the location of these two fat pads. We did see fat in the posterior left atrium -likely corresponding to at least one of the abovementioned fat pads -even though formal confirmation was not obtained using gross anatomic dissection of these collections of fibrofatty tissue. The absence of a formal correlative study comparing the previously defined GP locations with our immunohistochemical/functional data is a limitation of this paper. However our primary objective was to assess the underlying functional composition of the autonomic nervous system in each major region of the left atrium, and to assess the significance of the posterior left atrium as a therapeutic target for selective vagal denervation.
Although our study demonstrate a substantial reduction of atrial fibrillation inducibility by attenuation of the electrophysiologic effects of vagal stimulation on refractory periods, other potential mechanisms of AF as spontaneously triggered activity in the pulmonary veins may not be covered with this therapeutic approach.
In this study, we did not assess the relative importance of ganglion cells vs.
nerve fiber bundles/trunks in the creation of vagal AF substrate. While it would seem appropriate that the preferential target for ablation should be ganglion cells, we discovered that neuronal cell bodies and nerve fibers were co-localized in several nerve bundles (figure 4 and 6). We also discovered that while large collections of neuronal cells bodies (i.e. ganglia) are relatively sparsely located, the nerve fiber bundles that arise from these ganglion cells are frequently seen. Despite their greater number, nerve fiber bundles/trunks were always found to be in the vicinity of (or found to arise from/juxtaposed to) the neuronal cell bodies. This suggests that large nerve bundles/trunks may be a good surrogate for the presence of nerve cell bodies -and therefore provide a suitable ablation target. Regardless, more studies need to be performed to assess the relative contribution of nerve cell bodies vs nerve bundle/trunks to the autonomic physiology of the left atrium.
The contribution of the sympathetic innervation of the PLA and PVs to AF substrate was not examined in this study. Even though vagal innervation may be the 
